NasdaqGS:ADPTLife Sciences
Insider Sale At Adaptive Biotechnologies Versus clonoSEQ Growth And Valuation
Adaptive Biotechnologies (NasdaqGS:ADPT) President and COO Julie Rubinstein recently sold shares under a pre-arranged trading plan.
The transaction reduced her direct holdings and was executed as a scheduled, non-discretionary insider sale.
The sale comes as the company reports clonoSEQ revenue performance and points to a path toward profitability.
Adaptive Biotechnologies focuses on immune-driven diagnostics and uses its immune medicine platform to support blood cancer monitoring through...